adenosine monophosphate has been researched along with Stroke in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 7 (53.85) | 2.80 |
| Authors | Studies |
|---|---|
| Altintas, MO; Beker, MC; Caglayan, A; Caglayan, AB; Caglayan, B; Doeppner, TR; Hermann, DM; Kilic, E; Kilic, U; Pence, ME; Yagmur, S; Yelkenci, HE | 1 |
| Kaur, K; Kumar, M; Singh, TG | 1 |
| Feng, J; Hao, Y; Ma, D; Shang, P; Wang, X; Xin, M; Yin, X; You, J | 1 |
| Dabus, G; Linfante, I; Ravipati, K; Reyes, D; Starosciak, AK | 1 |
| Boulos, A; Dalfino, J; Entezami, P; Field, N; Holden, D; Paul, AR | 1 |
| Bourcier, R; Chalumeau, V; Clarençon, F; Consoli, A; Darcourt, J; Dargazanli, C; Delvoye, F; Desilles, JP; Elhorany, M; Finitsis, S; Gariel, F; Gory, B; Lapergue, B; Marnat, G; Mazighi, M; Richard, S; Sibon, I | 1 |
| Aghaebrahim, A; Agnoletto, GJ; Aguilar-Salinas, P; Brasiliense, LBC; Gonsales, D; Granja, MF; Hanel, RA; Santos, R; Sauvageau, E | 1 |
| Leonardi, S; Meani, P; Morici, N; Nava, S; Oliva, F; Oreglia, J; Ranucci, M; Rossini, R; Sacco, A; Viola, G | 1 |
| Fan, JY; Jin, C; Meng, J; Tang, XF; Yang, YJ; Yuan, JQ | 1 |
| Aksentijević, D; Brookes, PS; Chouchani, ET; Costa, ASH; Dare, AJ; Davidson, SM; Duchen, MR; Eaton, S; Eyassu, F; Frezza, C; Gaude, E; Hartley, RC; Hu, CH; James, AM; Krieg, T; Logan, A; Murphy, MP; Nadtochiy, SM; Ord, ENJ; Pell, VR; Robb, EL; Robinson, AJ; Rogatti, S; Saeb-Parsy, K; Shattock, MJ; Shirley, R; Smith, AC; Sundier, SY; Work, LM | 1 |
| Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Sawlani, NN; Steg, PG; Stone, GW; White, HD | 1 |
| Akiyama, Y; Hiwatashi, K; Komai, M; Koseki, T; Shirakawa, H; Takahasi, S | 1 |
| Grieco, G; Jonas, S | 1 |
3 review(s) available for adenosine monophosphate and Stroke
| Article | Year |
|---|---|
Cyclic adenosine monophosphate in acute ischemic stroke: some to update, more to explore.
Topics: Adenosine Monophosphate; Brain Ischemia; Endothelial Cells; Humans; Ischemic Stroke; Stroke | 2020 |
Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: a meta-analysis of randomized trials.
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Administration, Oral; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Fibrinolytic Agents; Hemorrhage; Humans; Injections, Intravenous; Multicenter Studies as Topic; Myocardial Infarction; Piperazines; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Stents; Stroke; Sulfonamides; Thiophenes; Thrombolytic Therapy; Ticagrelor; Ticlopidine | 2014 |
Potential value of triple antiplatelet therapy for secondary stroke prevention.
Topics: Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk; Stroke; Treatment Outcome | 2003 |
10 other study(ies) available for adenosine monophosphate and Stroke
| Article | Year |
|---|---|
Phosphodiesterase 10A deactivation induces long-term neurological recovery, Peri-infarct remodeling and pyramidal tract plasticity after transient focal cerebral ischemia in mice.
Topics: Adenosine Monophosphate; Animals; Atrophy; beta-Synuclein; Chromatography, Liquid; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Mice; Phosphoric Diester Hydrolases; Proteasome Endopeptidase Complex; Protein Phosphatase 1; Pyramidal Tracts; Receptors, Dopamine; Stroke; Tandem Mass Spectrometry | 2022 |
Neuroprotective Effects of Carbonic Anhydrase Inhibition and Cyclic Adenosine Monophosphate Activation in Mouse Model of Transient Global Cerebral Ischemia and Reperfusion.
Topics: Acetylcholinesterase; Adenosine Monophosphate; Animals; Brain Ischemia; Colforsin; Dichlorphenamide; Ischemic Attack, Transient; Mice; Neuroprotective Agents; Reperfusion; Reperfusion Injury; Stroke | 2023 |
Intravenous cangrelor and oral ticagrelor as an alternative to clopidogrel in acute intervention.
Topics: Adenosine Monophosphate; Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Clopidogrel; Endovascular Procedures; Female; Humans; Male; Middle Aged; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Self Expandable Metallic Stents; Stroke; Subarachnoid Hemorrhage; Ticagrelor; Treatment Outcome | 2021 |
Use of intravenous cangrelor and stenting in acute ischemic stroke interventions: a new single center analysis and pooled-analysis of current studies.
Topics: Adenosine Monophosphate; Brain Ischemia; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Stents; Stroke; Treatment Outcome | 2021 |
A Multicenter Preliminary Study of Cangrelor following Thrombectomy Failure for Refractory Proximal Intracranial Occlusions.
Topics: Adenosine Monophosphate; Humans; Prospective Studies; Retrospective Studies; Stroke; Thrombectomy; Treatment Outcome | 2021 |
Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single-center pilot study.
Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Drug Therapy, Combination; Endovascular Procedures; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stents; Stroke; Thrombectomy; Treatment Outcome | 2019 |
Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor?
Topics: Adenosine Monophosphate; Aged; Aged, 80 and over; Biomarkers; Disease Management; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stroke; Time-to-Treatment; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.
Topics: Adenosine Monophosphate; Animals; Aspartic Acid; Citric Acid Cycle; Disease Models, Animal; Electron Transport; Electron Transport Complex I; Fumarates; Ischemia; Malates; Male; Metabolomics; Mice; Mitochondria; Myocardial Infarction; Myocardium; Myocytes, Cardiac; NAD; Reactive Oxygen Species; Reperfusion Injury; Stroke; Succinate Dehydrogenase; Succinic Acid | 2014 |
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention.
Topics: Adenosine Monophosphate; Aged; Brain Ischemia; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Novel effect of adenosine 5'-monophosphate on ameliorating hypertension and the metabolism of lipids and glucose in stroke-prone spontaneously hypertensive rats.
Topics: Adenosine Monophosphate; Animals; Blood Glucose; Cholesterol, HDL; Diet; Hyperglycemia; Hyperlipidemias; Hypertension; Liver; Male; Nitric Oxide; Rats; Rats, Inbred SHR; RNA, Messenger; Stroke; Triglycerides | 2011 |